locally advanced head and neck squamous cell carcinoma

Showing 1 - 20 of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (volrustomig)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Prescott Valley, Arizona
  • +71 more
Nov 10, 2023

TPExtreme Induced Chemotherapy Followed by Surgery and

Recruiting
  • Oral Squamous Cell Carcinoma
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Modified radical surgery
  • Radical surgery
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
May 14, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Tianjin, China
  • +1 more
May 16, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Mar 20, 2023

Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • RP3
  • +3 more
  • (no location specified)
Feb 21, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Xevinapant, Placebo)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Feb 10, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Columbus (Counseling, Dietary Counseling and Surveillance,

Active, not recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Counseling
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 5, 2023

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 6, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Hamilton, London, Toronto (High-Dose Cisplatin, Low-Dose

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • High-Dose Cisplatin
  • +2 more
  • Hamilton, Ontario, Canada
  • +2 more
Jun 7, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (NBTXR3, Cetuximab, Radiation Therapy)

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Tampa, Florida
  • +17 more
Mar 22, 2022

Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Beijing, Beijing, China
  • +4 more
Mar 3, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +5 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 17, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck

Recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +5 more
  • Pembrolizumab (immunotherapy)
  • Quad-shot palliative radiotherapy
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Feb 7, 2022

Locally Advanced Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Zhuhai (PD-1 inhibitor+ Gemcitabine +

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • PD-1 inhibitor+ Gemcitabine + Cisplatin
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Jun 23, 2021

Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced Hypopharyngeal Squamous Cell Carcinoma, Locally

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • +18 more
  • Proton Beam Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 30, 2021

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Seoul (genexolPM + cisplatin)

Completed
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • genexolPM + cisplatin
  • Seoul, Korea, Republic of
  • +1 more
Dec 4, 2020

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Guiyang (Lobaplatin, Cisplatin)

Unknown status
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Guiyang, Guizhou, China
    Cancer Hospital of Guizhou Medical University
Apr 14, 2017